Plain-English translation of NCT01087333 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study collecting blood and tissue samples from people with blood cancers—especially hairy cell leukemia—and from healthy volunteers without cancer. The goal is to better understand how these cancers work and to develop and test new treatments called recombinant immunotoxins, which are designed to target and kill cancer cells more precisely than traditional chemotherapy.
Hairy cell leukemia and related blood cancers are difficult to cure with standard treatments, and some variants are especially aggressive and resistant to therapy. By studying samples from patients and comparing them to healthy people, researchers hope to find more effective treatments and understand why some cancers respond better than others.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would visit the research clinic where doctors and nurses would collect blood samples and possibly other tissue samples for laboratory testing. The study team will also review your medical records and may ask you questions about your health history. Depending on your group (cancer patient or healthy volunteer), the researchers may ask you to return for follow-up visits over time so they can track how your condition changes and continue to gather information.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United States